Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 2Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1Esophageal Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 9Doxorubicin 8Vincristine 6Etoposide 6Ifosfamide 5Filgrastim 5Radiotherapy 4fludarabine phosphate 3Topotecan 3Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Cisplatin 3Carboplatin 3seclidemstat 2Temozolomide 2Tacrolimus 2Neoadjuvant Therapy 2Irinotecan 2Injections 2Hyperthermic Intraperitoneal Chemotherapy 2Granulocyte Colony-Stimulating Factor 2Epirubicin 2Dactinomycin 2Cytoreduction Surgical Procedures 2Cyclosporine 2Chemotherapy, Adjuvant 2Brachytherapy 2thymoglobulin 1tazemetostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Desmoplastic Small Round Cell Tumor × Ramucirumab × Sarcoma × Clear all
NCT04145349 2026-05-11

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Eli Lilly and Company

Phase 1/2 Completed
30 enrolled 16 charts
Sarcoma

Sarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡